对话分析
宏观分析
个别股票
Alpha 实验室
实用工具
Menu
我的活动
ZH
登录
ZH
暴涨分析
/
Drugs Made In America Acquisition Corp.
/
2026-07-21
▲ SURGE
Drugs Made In America Acquisition Corp.
+54.5%
DMAAR
NASDAQ
2026-07-21
0.17
收盘价
0.11
前收盘价
+54.45%
涨幅
65.8x
量比
暴涨原因
2026년 5월 5일, Drugs Made In America Acquisition Corp.은 PAGC와의 합병 계약(Merger Deal)을 발표하였다.
·
2026년 5월 5일, Drugs Made In America Acquisition Corp.은 PAGC와의 합병 계약(Merger Deal)을 발표하였다.
相关新闻
Drugs Made In America Acquisition Announces PAGC Merger Deal
Tipranks
2026-05-05
Larimar stock surges on FDA breakthrough status (LRMR:NASDAQ)
Seekingalpha
2026-02-24
TherapeuticsMD Inc. stock outperforms competitors on strong trading day
Marketwatch
2026-05-18
HC Wainwright & Co. Assumes Larimar Therapeutics at Buy, Announces Price Target of $10 - Larimar Therapeu
Benzinga
2026-07-02
Meadowbrook Advisors Group LLC Purchases New Holdings in Applied Materials, Inc. $AMAT
Zolmax
2026-06-20
技术分析
信号
布林上轨突破
超买
MACD看涨
站上SMA20
关键指标
72.12
RSI (14)
0.11
SMA 20
0.08
Bollinger Lower
0.14
Bollinger Upper
0.11
Bollinger Mid
0.00
MACD
0.00
MACD Signal
0.00
MACD Hist
查看股票详情
返回暴涨股列表
首页
聊天
组合
活动
菜单
Drugs Made In America Acquisition Corp. +54.5% 暴涨分析 (2026-07-21) | Alpha Lenz